REFERENCES
- Khan AO, Nowilaty SR. Early diagnosis of the papillorenal syndrome by optic disc morphology. J Neuroophtalmol. 2005; 25(3)209–211
- Waubant E, Sadovnick AD. Interferon beta babies. Neurology. 2005; 65(6)807–811
- Ferrero S, Pretta S, Ragni N. Multiple sclerosis: Management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2004; 115(1)3–9
- Schimmenti LA, Manligas GS, Sieving PA. Optic nerve dysplasia and renal insufficiency in a family with a novel PAX2 mutation, Arg115X: Further ophtalmologic delineation of the renal-coloboma syndrome. Ophtalmic Gene. 2003; 24(4)191–202
- Sanyanusin P, McNoe LA, Sullivan MJ, et al. Mutation of PAX2 in two siblings with renal-coloboma syndrome. Hum Mol Genet. 1995; 4: 2183–2184
- Eccles MR, Schimmenti LA. Renal-coloboma syndrome: A multi-system developmental disorder caused by PAX2 mutations. Clin Genet. 1999; 56(1)1–9
- Sanyanusin P, Schimmenti LA, McNoe LA, et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nature Genet. 1995; 9: 358–364
- Cunliffe HE, McNoe LA, Ward TA, et al. The prevalence of PAX2 mutations in patients with isolated colobomas or colobomas associated with urogenital anomalies. J Med Genet. 1998; 35: 806–812
- Schimmenti LA, Shim HH, Wirtschafter JD, et al. Homonucleotide expansion and contraction mutations of PAX2 and inclusion of Chiari 1 malformation as part of renal-coloboma syndrome. Hum Mutat. 1999; 14: 369–376
- Higashide T, Wada T, Sakurai M, et al. Macular abnormalities and optic disk anomaly associated with a new PAX2 missence mutation. Am J Ophtalmol. 2005; 139(1)203–205
- Porteus S, Torban E, Cho NP, et al. Primary renal hypoplasia in humans and mice with PAX2 mutations: Evidence of increased apoptosis in fetal kidneys of PAX21Neu +/- mutatnt mice. Hum Mol Genet. 2000; 9: 1–11
- Yoshimura K, Yoshida S, Yamaji Y, et al. De novo insG619 mutation in PAX2 gene in a Japanese patient with papillorenal syndrome. Am J Ophtalmol. 2005; 139(4)733–735
- Weber S, Moriniere V, Knüppel T, et al. Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: Results of the ESCAPE study. J Am Soc Nephrol. 2006; 17(10)2864–2870
- Nishimoto K, Iijima K, Shirakawa T, et al. PAX2 gene mutation in a family with isolated renal hypoplasia. J Am Soc Nephrol. 2001; 12: 1769–1772
- Weaver RG, Cashwell LF, Lorentz W, et al. Optic nerve coloboma associated with renal disease. Am J Med Genet. 1988; 29: 597–605
- Amiel J, Audollent S, Joly D, et al. PAX2 mutations in renal-coloboma syndrome: Mutational hotspot and germline mosaicism. Eur J Hum Genet. 2000; 8: 820–826
- Fletcher J, Hu M, Berman Y, et al. Multicystic dysplastic kidney and variable phenotype in a family with a novel deletion mutation of PAX2. J Am Soc Nephrol. 2005; 16(9)2754–2761
- Salomon R, Tellier AL, Attie-Bitach T, et al. PAX2 mutations in oligomeganephronia. Kidney Int. 2001; 59(2)457–462
- Dureau P, Attie-Bitach T, Salomon R, et al. Renal coloboma syndrome. Ophthalmology. 2001; 108(10)1912–1916
- Parsa CF, Silva ED, Sundin OH, et al. Redefining papillorenal syndrome: An underdiagnosed cause of ocular and renal morbidity. Ophthalmology. 2001; 108: 738–749
- Theodossiadis PG, Stringaris K, Papadopoulos V, et al. Optic nerve cyst associated with optic disk pits. Graefes Arch Clin Exp Ophthalmol. 2005; 243(7)718–720
- Sandberg-Wollheim M, Frank D, Goodwin TM, et al. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology. 2005; 65(6)788–789
- Chard T. Interferon in pregnancy. J Dev Physiol. 1980; 11: 271–276
- Boskovic R, Wide R, Wolpin J, et al. The reproductive effects of beta interferon therapy in pregnancy: A longitudinal cohort. Neurology. 2005; 65(6)788–789